Definium Therapeutics

DFTXNasdaq United States Health Care Medicinal Chemicals and Botanical Products

Market cap

$5.032 B

$46.14 +0.00%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$183.8M

Loss-making

Shares outstanding

134,366,950

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medicinal Chemicals and Botanical Products — ranked by market cap

All 26 →

#2British American Tobacco p.l.c.BTI$128.6B
#3Altria GroupMO$114.1B
#4Definium TherapeuticsDFTX$5.03B
#5RLX TechnologyRLX$3.11B
#6Regencell BioscienceRGC$2.68B

Where these numbers come from

Share counts and financials for Definium Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.